Browse studies

Find your next paid study

3,080 recruiting studies matching your filters

Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia

Alzheimer's Disease and related dementias (AD/ADRD) are common and debilitating conditions. Financial hardship, a multidimensional construct of financial strai…

Financial HardshipAlzheimer's Disease (AD)Alzheimer's Disease and Related Dementia (ADRD)

Estimated

~$10 – $750

Actual pay is set by the research site.

Fred Hutchinson Cancer CenterNCT06922188

Phase 2

A Multi-center Trial Evaluating the ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab for Advanced Melanoma

The purpose of this study is to investigate the use of ctDNA measurements to guide first-lien therapy choice for patients with advanced or metastatic melanoma.…

Metastatic MelanomaAdvanced Melanoma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

NYU Langone HealthNCT07504796

Phase 1

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

The purpose of this research is to see if adding blood-based tests and symptom review to standard-of-care pancreatic cancer screening procedures can identify c…

Pancreatic CancerPancreatic Ductal AdenocarcinomaPDAC+2 more

Estimated

~$500 – $11,250

Actual pay is set by the research site.

Dana-Farber Cancer InstituteNCT06122896

Phase 2

Phase II Trial of Enfortumab Vedotin in Recurrent and/or Metastatic Adenoid Cystic Carcinoma

The purpose of this study is to find out whether enfortumab vedotin is an effective and safe treatment for people with adenoid cystic carcinoma (ACC).

Adenoid Cystic Carcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT06891560

Phase 1

A Multicenter Open-label, Prospective Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.

Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

UCB Biopharma SRLNCT06888193

Observational

Evaluating Health Outcomes of AI-Based Fitness Wearables and App Programs in Older Adults Living Alone With Cognitive Decline

The overarching goal of our research is to develop personalized and accessible healthy aging lifestyle interventions aimed at promoting physical activity (PA) …

Older Adults With Cognitive DeclineOlder AdultsAI-Based Fitness+4 more

Estimated

~$10 – $750

Actual pay is set by the research site.

The University of Tennessee, KnoxvilleNCT07207993

Phase 1

A Phase 1 Study to Establish the Feasibility of Enolen (tm) for the Local Delivery of Enzalutamide in Patients With Prostate Cancer

The study is to assess whether the Enolen is safe and delivers anti-androgen medication locally in patients that are planning for radical prostatectomy.

Prostate Adenocarcinoma

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Alessa Therapeutics Inc.NCT06257693

Advanced SPinal Innovations With Robotics and Enabling Technology Registry

Creation of a pediatric robotic spine surgery registry will allow for data collection and analysis on the coupled use of robotics and navigation, as well as pa…

Spine DeformityIdiopathic ScoliosisAdolescent Idiopathic Scoliosis+3 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Children's HospitalNCT05071144

Adrenoleukodystrophy National Registry Study

The aim of this registry to understand the natural history and disease progression in ALD and potentially develop bio-markers using the biospecimens collected …

ALD (Adrenoleukodystrophy)AdrenoleukodystrophyCerebral Adrenoleukodystrophy

Estimated

~$10 – $750

Actual pay is set by the research site.

Masonic Cancer Center, University of MinnesotaNCT03789721

Observational Study of Commercial Chimeric Antigen Receptor T-cell (CAR T) Therapy in Older Patients With Hematologic Malignancies and With an Embedded Pilot Study of Longitudinal Geriatric and Neurocognitive Evaluation

This study is being done to find out how older patients respond to CAR-T cell therapy and how the treatment affects their quality of life. This is a quality of…

LymphomaRefractory B-Cell LymphomaLymphoma, B-Cell+3 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT04300998

Phase 3

Comparative Effectiveness of Two Initial Combination Therapies in Patients With New Onset Diabetes

The primary purpose of this study is to evaluate the efficacy, durability, and mechanism of HbA1c reduction produced by the combination of pioglitazone plus ti…

Type 2 Diabetes (Adult Onset)

Estimated

~$50 – $1,500

Actual pay is set by the research site.

The University of Texas Health Science Center at San AntonioNCT06246799

Phase 3

RASolute 304: A Phase 3 Multicenter, Open-label, Randomized, 2-Arm Study of Adjuvant Daraxonrasib Versus Standard of Care Observation Following Completion of Neoadjuvant and/or Adjuvant Chemotherapy in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.

Pancreatic CancerPDACPDAC - Pancreatic Ductal Adenocarcinoma+2 more

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Revolution Medicines, Inc.NCT07252232